ACADIA PHARMACEUTICALS INC (ACAD) Class Action Lawsuit (July 2018)

Closed

3:18cv1647 • July 19, 2018

Class Period Start

April 29, 2016

Class Period End

July 9, 2018

PSLRA Deadline

September 17, 2018

Case Allegations

10b5

Statutes of Repose

Apr 29, 2019

Country

United States

Court

Federal Court

Docket History

Jan 3, 2022

Motion to Dismiss Granted (opens in a new tab)

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

May 31, 2021

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Apr 16, 2021

Third Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Mar 29, 2021

Motion to Dismiss Granted (opens in a new tab)

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Aug 28, 2020

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jul 16, 2020

Second Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jun 1, 2020

Motion to Dismiss Denied in Part (opens in a new tab)

The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.

Jun 7, 2019

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Apr 15, 2019

First Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Feb 26, 2019

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jul 23, 2018

Additional Complaint (opens in a new tab)

Another plaintiff has filed a complaint on behalf of investors in ACADIA PHARMACEUTICALS INC. The allegations and class definitions are substantively the same.

Jul 19, 2018

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC.